Literature DB >> 20010071

Targeting Trojan Horse leukocytes for HIV prevention.

Deborah J Anderson1, Joseph A Politch, Adam M Nadolski, Caitlin D Blaskewicz, Jeffrey Pudney, Kenneth H Mayer.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20010071      PMCID： PMC4097178          DOI： 10.1097/QAD.0b013e32833424c8

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  305 in total

1.  Quantification of HIV in semen: correlation with antiviral treatment and immune status.

Authors:  P L Vernazza; B L Gilliam; J Dyer; S A Fiscus; J J Eron; A C Frank; M S Cohen
Journal:  AIDS       Date:  1997-07       Impact factor: 4.177

2.  The removal of morphologically abnormal sperm forms by phagocytes: a positive role for seminal leukocytes?

Authors:  M J Tomlinson; A White; C L Barratt; A E Bolton; I D Cooke
Journal:  Hum Reprod       Date:  1992-04       Impact factor: 6.918

Review 3.  The role of sexually transmitted diseases in HIV transmission.

Authors:  Shannon R Galvin; Myron S Cohen
Journal:  Nat Rev Microbiol       Date:  2004-01       Impact factor: 60.633

Review 4.  HIV and reproductive care--a review of current practice.

Authors:  C Gilling-Smith; J D M Nicopoullos; A E Semprini; L C G Frodsham
Journal:  BJOG       Date:  2006-06-02       Impact factor: 6.531

Review 5.  HIV chemokine receptor inhibitors as novel anti-HIV drugs.

Authors:  Katrien Princen; Dominique Schols
Journal:  Cytokine Growth Factor Rev       Date:  2005-07-06       Impact factor: 7.638

6.  Immunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone.

Authors:  Jeffrey Pudney; Alison J Quayle; Deborah J Anderson
Journal:  Biol Reprod       Date:  2005-08-10       Impact factor: 4.285

7.  Selenium deficiency is associated with shedding of HIV-1--infected cells in the female genital tract.

Authors:  J M Baeten; S B Mostad; M P Hughes; J Overbaugh; D D Bankson; K Mandaliya; J O Ndinya-Achola; J J Bwayo; J K Kreiss
Journal:  J Acquir Immune Defic Syndr       Date:  2001-04-01       Impact factor: 3.731

8.  Safety of sperm washing and ART outcome in 741 HIV-1-serodiscordant couples.

Authors:  V Savasi; E Ferrazzi; C Lanzani; M Oneta; B Parrilla; T Persico
Journal:  Hum Reprod       Date:  2006-11-15       Impact factor: 6.918

9.  Inhibitory effect of PRO 2000, a candidate microbicide, on dendritic cell-mediated human immunodeficiency virus transfer.

Authors:  Natalia Teleshova; Theresa Chang; Albert Profy; Mary E Klotman
Journal:  Antimicrob Agents Chemother       Date:  2008-03-10       Impact factor: 5.191

Review 10.  Topical application of entry inhibitors as "virustats" to prevent sexual transmission of HIV infection.

Authors:  Michael M Lederman; Robin Jump; Heather A Pilch-Cooper; Michael Root; Scott F Sieg
Journal:  Retrovirology       Date:  2008-12-18       Impact factor: 4.602
View more
  75 in total

1.  In vitro activities of candidate microbicides against cell-associated HIV.

Authors:  Philippe Selhorst; Katrijn Grupping; Thomas Bourlet; Olivier Delézay; Kevin K Ariën; Guido Vanham
Journal:  Antimicrob Agents Chemother       Date:  2011-11-14       Impact factor: 5.191

2.  MIV-150/zinc acetate gel inhibits cell-associated simian-human immunodeficiency virus reverse transcriptase infection in a macaque vaginal explant model.

Authors:  Patrick Barnable; Giulia Calenda; Thierry Bonnaire; Radhika Menon; Keith Levendosky; Agegnehu Gettie; James Blanchard; Michael L Cooney; José A Fernández-Romero; Thomas M Zydowsky; Natalia Teleshova
Journal:  Antimicrob Agents Chemother       Date:  2015-04-13       Impact factor: 5.191

3.  Detection of Simian Immunodeficiency Virus in Semen, Urethra, and Male Reproductive Organs during Efficient Highly Active Antiretroviral Therapy.

Authors:  G Matusali; N Dereuddre-Bosquet; A Le Tortorec; M Moreau; A-P Satie; D Mahé; P Roumaud; O Bourry; N Sylla; S Bernard-Stoecklin; A Pruvost; R Le Grand; N Dejucq-Rainsford
Journal:  J Virol       Date:  2015-04-01       Impact factor: 5.103

4.  Mobile Health Intervention to Reduce HIV Transmission: A Randomized Trial of Behaviorally Enhanced HIV Treatment as Prevention (B-TasP).

Authors:  Seth C Kalichman; Chauncey Cherry; Moira O Kalichman; Lisa A Eaton; James J Kohler; Catherine Montero; Raymond F Schinazi
Journal:  J Acquir Immune Defic Syndr       Date:  2018-05-01       Impact factor: 3.731

Review 5.  Adding new dimensions: towards an integrative understanding of HIV-1 spread.

Authors:  Oliver T Fackler; Thomas T Murooka; Andrea Imle; Thorsten R Mempel
Journal:  Nat Rev Microbiol       Date:  2014-08       Impact factor: 60.633

6.  Structure and function of intercellular junctions in human cervical and vaginal mucosal epithelia.

Authors:  Caitlin D Blaskewicz; Jeffrey Pudney; Deborah J Anderson
Journal:  Biol Reprod       Date:  2011-04-06       Impact factor: 4.285

7.  Slaying the Trojan horse: natural killer cells exhibit robust anti-HIV-1 antibody-dependent activation and cytolysis against allogeneic T cells.

Authors:  Shayarana L Gooneratne; Jonathan Richard; Wen Shi Lee; Andrés Finzi; Stephen J Kent; Matthew S Parsons
Journal:  J Virol       Date:  2014-10-15       Impact factor: 5.103

8.  The HIV-1 viral synapse signals human foreskin keratinocytes to secrete thymic stromal lymphopoietin facilitating HIV-1 foreskin entry.

Authors:  Z Zhou; L Xu; A Sennepin; C Federici; Y Ganor; D Tudor; D Damotte; N Barry Delongchamps; M Zerbib; M Bomsel
Journal:  Mucosal Immunol       Date:  2017-04-26       Impact factor: 7.313

9.  Highly active antiretroviral therapy does not completely suppress HIV in semen of sexually active HIV-infected men who have sex with men.

Authors:  Joseph A Politch; Kenneth H Mayer; Seth L Welles; William X O'Brien; Chong Xu; Frederick P Bowman; Deborah J Anderson
Journal:  AIDS       Date:  2012-07-31       Impact factor: 4.177

Review 10.  Rectal microbicide development.

Authors:  Ian McGowan; Charlene Dezzutti
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.